Related Experiment Video

Updated: May 9, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Conserved sequence motifs and the structure of the mTOR kinase domain

Evelyn Sauer1, Stefan Imseng, Timm Maier

  • 1Biozentrum, University of Basel, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland.

Biochemical Society Transactions
|July 19, 2013
PubMed

Insights

The mammalian target of rapamycin (mTOR) kinase domain structure was elucidated, validating a previously developed homology model. This provides crucial insights for developing mTOR inhibitors for cancer therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • The mammalian target of rapamycin (mTOR) is a key regulator of cell growth and metabolism, operating within mTORC1 and mTORC2 complexes.
  • Understanding mTOR's structure is crucial for developing targeted cancer therapies, but high-resolution structural data has been limited.

Purpose of the Study:

  • To analyze and validate a homology model of the mTOR kinase domain using the recently determined crystal structure.
  • To provide structural insights into mTOR's architecture and regulation.

Main Methods:

  • Homology modeling of the mTOR kinase domain based on phosphoinositide 3-kinase (PI3K) structures.
  • Analysis and comparison of the homology model with the experimentally determined crystal structure of human mTOR catalytic domain.

Main Results:

  • The crystal structure of the human mTOR catalytic domain was determined, offering significant structural insights.
  • The previously generated homology model accurately predicted several features of the crystal structure.
  • This study revisits the homology model in light of the new crystal structure data.

Conclusions:

  • The crystal structure of the mTOR kinase domain provides essential information for understanding its function and regulation.
  • The validated homology model serves as a valuable tool, especially for the design of mTOR inhibitors.
  • Structural insights facilitate the development of novel anti-cancer agents targeting mTOR signaling.

More Related Videos

Identification of Kinase-substrate Pairs Using High Throughput Screening11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Conservation of Protein Domains Over Different Proteins02:26

Conservation of Protein Domains Over Different Proteins

Protein domains are small structurally independent units that are part of a single amino acid chain.  Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to form...